You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Janus kinase inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sjogren's Syndrome Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (tofacitinib, Placebo)

Recruiting
  • Sjogren's Syndrome
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 24, 2022

Janus Kinase Inhibitor Therapy in Ulcerative Colitis

Terminated
  • Ulcerative Colitis
  • Janus Kinase Inhibitor
  • Amsterdam, North Halland, Netherlands
    Amsterdam Medical Center, IBD Center
Dec 14, 2021

Abatacept, Treatment Compliance, Rheumatoid Arthritis Trial in Hangzhou (Janus Kinase Inhibitor, Abatacept)

Recruiting
  • Abatacept
  • +2 more
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Jul 5, 2022

COVID-19 Trial in Halifax (Baricitinib (janus kinase inhibitor), Remdesivir (antiviral) + barictinib (janus kinase inhibitor),

Recruiting
  • COVID-19
  • Baricitinib (janus kinase inhibitor)
  • +3 more
  • Halifax, Nova Scotia, Canada
    Nova Scotia Health Authority
Mar 9, 2022

Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV2 Trial in Sao Paulo (Janus Kinase Inhibitor (ruxolitinib), Placebo)

Terminated
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • SARS-CoV2
  • Janus Kinase Inhibitor (ruxolitinib)
  • Placebo
  • Sao Paulo, Brazil
    Hospital das Clínicas
Apr 5, 2021

Non-sclerotic Cutaneous Chronic Graft-versus-host Disease Trial in New York (topical ruxolitinib 1.5% cream, Topical

Recruiting
  • Non-sclerotic Cutaneous Chronic Graft-versus-host Disease
  • topical ruxolitinib 1.5% cream
  • Topical vehicle/moisturizer cream
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 20, 2022

Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +13 more
Jan 10, 2023

Sarcoidosis Trial in New Haven (Abrocitinib 200 mg)

Not yet recruiting
  • Sarcoidosis
  • Abrocitinib 200 mg
  • New Haven, Connecticut
    Yale University
Jan 24, 2023

Alopecia Areata Trial in Sohag (Janus Kinase 1 and 2)

Recruiting
  • Alopecia Areata
  • Janus Kinase 1 and 2
  • Sohag, Egypt
    Sohag University hospitals
May 12, 2023

Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV-MF), Post-Essential Thrombocythemia Myelofibrosis

Recruiting
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Glendale, California
  • +28 more
May 5, 2022

Myelofibrosis Trial in Worldwide (TL-895)

Recruiting
  • Myelofibrosis
  • Aurora, Colorado
  • +65 more
Jun 2, 2022

Idiopathic Inflammatory Myopathies Trial in Beijing (tofacitinib)

Recruiting
  • Idiopathic Inflammatory Myopathies
  • Beijing, Beijing, China
    Department of Rheumatology and Immunology, Peking University Peo
Oct 9, 2022

Chronic Kidney Diseases Trial in Durham (Baricitinib, Placebo)

Recruiting
  • Chronic Kidney Diseases
  • Durham, North Carolina
    Duke Research at Pickett Road
Dec 15, 2022

Myelofibrosis Trial in Worldwide (Imetelstat 4.7 mg/kg, Imetelstat 9.4 mg/kg)

Completed
Has Results
  • Myelofibrosis
  • Imetelstat 4.7 mg/kg
  • Imetelstat 9.4 mg/kg
  • Birmingham, Alabama
  • +71 more
Aug 17, 2021

Acute Lung Injury (ALI) Associated With COVID-19, Lung Inflammation Associated With COVID-19 Trial in Worldwide (TD-0903,

Completed
Has Results
  • Acute Lung Injury (ALI) Associated With COVID-19
  • Lung Inflammation Associated With COVID-19
  • Duarte, California
  • +23 more
Mar 15, 2022

Janus Kinase Inhibitors Vs Tumor Necrosis Factor Inhibitors in

Not yet recruiting
  • Rheumatoid Arthritis
  • Observation
  • (no location specified)
Oct 8, 2022

Granuloma Annulare Trial in New Haven (Abrocitinib 200 mg)

Not yet recruiting
  • Granuloma Annulare
  • Abrocitinib 200 mg
  • New Haven, Connecticut
    Yale University
Dec 19, 2022

Relapsed or Refractory Peripheral T Cell Lymphoma Trial in Worldwide (AZD4205)

Recruiting
  • Relapsed or Refractory Peripheral T Cell Lymphoma
  • New Haven, Connecticut
  • +50 more
Jan 27, 2022

Nonsmall Cell Lung Cancer Trial in Sydney, Heidelberg, Melbourne (AZD4205)

Completed
  • Nonsmall Cell Lung Cancer
  • Sydney, New South Wales, Australia
  • +3 more
Aug 20, 2020

Pancreatic Ductal Adenocarcinoma Trial (combination therapy with no MEKi, combination therapy with MEKi-HCQ, combination therapy

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • combination therapy with no MEKi
  • +3 more
  • (no location specified)
Nov 29, 2022

Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase

Recruiting
  • Liver Transplant
  • PVHA or TACE
  • Shanghai, Shanghai, China
    The value of tumor feeding vessels deprivation combined with tyr
Nov 26, 2022

Cushing Disease Trial (Fimepinostat)

Not yet recruiting
  • Cushing Disease
  • (no location specified)
Jul 31, 2023

Diabetes, Type 1 Trial (Abrocitinib 200 MG Oral Tablet, Ritlecitinib, Placebo)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Abrocitinib 200 MG Oral Tablet
  • +2 more
  • (no location specified)
Feb 21, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial (PEP07)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Aug 1, 2023

Liver Tumors Trial in Beijing (Tislelizumab plus tyrosine kinase inhibitor)

Recruiting
  • Liver Neoplasms
  • Tislelizumab plus tyrosine kinase inhibitor
  • Beijing, Beijing, China
    302 Hospital
Sep 22, 2023